View in EDS HTML Full Text PDF Full Text

Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [ 177 Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [ 177 Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.
Authors: Zavvar, Taraneh Sadat1 (AUTHOR), Santo, Giulia1,2 (AUTHOR), Gruber, Leonhard2,3 (AUTHOR), Kronthaler, Ariane1,4 (AUTHOR), Hagenbuchner, Judith3,5 (AUTHOR), Skvortsova, Ira4,5,6 (AUTHOR), Piro, Inken6,7 (AUTHOR), Steiger, Katja6,8 (AUTHOR), Martinovic, Vladan1,7 (AUTHOR), Minasch, Danijela2,8 (AUTHOR), Löffler-Ragg, Judith3,7 (AUTHOR), di Santo, Gianpaolo1,4 (AUTHOR), Virgolini, Irene J.1,5 (AUTHOR), von Guggenberg, Elisabeth1,6 (AUTHOR) elisabeth.von-guggenberg@i-med.ac.at
Source: Pharmaceutics. Jan2026, Vol. 18 Issue 1, p138. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19994923
DOI:10.3390/pharmaceutics18010138